CA2881213A1 - Compositions antigeniques de chlamydia et leurs utilisations - Google Patents

Compositions antigeniques de chlamydia et leurs utilisations Download PDF

Info

Publication number
CA2881213A1
CA2881213A1 CA2881213A CA2881213A CA2881213A1 CA 2881213 A1 CA2881213 A1 CA 2881213A1 CA 2881213 A CA2881213 A CA 2881213A CA 2881213 A CA2881213 A CA 2881213A CA 2881213 A1 CA2881213 A1 CA 2881213A1
Authority
CA
Canada
Prior art keywords
chlamydia
protein
composition
pmpg
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2881213A
Other languages
English (en)
Inventor
Robert C. Brunham
Karuna P. KARUNAKARAN
Hong Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of CA2881213A1 publication Critical patent/CA2881213A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne en partie des protéines de fusion issues de Chlamydia spp. La présente invention concerne également en partie des méthodes de traitement ou de prévention d'une infection par Chlamydia à l'aide des protéines de fusion.
CA2881213A 2012-08-08 2013-08-08 Compositions antigeniques de chlamydia et leurs utilisations Abandoned CA2881213A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261680836P 2012-08-08 2012-08-08
US61/680,836 2012-08-08
PCT/CA2013/050610 WO2014022936A1 (fr) 2012-08-08 2013-08-08 Compositions antigéniques de chlamydia et leurs utilisations

Publications (1)

Publication Number Publication Date
CA2881213A1 true CA2881213A1 (fr) 2014-02-13

Family

ID=50067339

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2881213A Abandoned CA2881213A1 (fr) 2012-08-08 2013-08-08 Compositions antigeniques de chlamydia et leurs utilisations

Country Status (3)

Country Link
CN (1) CN104812406A (fr)
CA (1) CA2881213A1 (fr)
WO (1) WO2014022936A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103987404A (zh) * 2011-09-30 2014-08-13 英属哥伦比亚大学 衣原体抗原组合物及其用途
JP2020526567A (ja) * 2017-07-13 2020-08-31 ナノビオ コーポレイションＮａｎｏｂｉｏ Ｃｏｒｐｏｒａｔｉｏｎ クラミジアナノエマルジョンワクチン
EP4032545A1 (fr) 2021-01-26 2022-07-27 Medizinische Hochschule Hannover Composition immunogène et vaccin contenant des antigènes de surface du chlamydia spp. et son utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2218730A1 (fr) * 1997-11-28 2010-08-18 Merck Serono Biodevelopment Séquence génomique de Chlamydia pneumoniae, polypeptides, fragments et leurs utilisations, en particulier pour le diagnostic, la prévention et le traitement de l'infection
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
EP1868641A2 (fr) * 2005-03-31 2007-12-26 GlaxoSmithKline Biologicals SA Vaccins destines a lutter contre une infection a chlamydia
US20120027793A1 (en) * 2009-01-29 2012-02-02 British Columbia Cancer Agency Branch Compositions comprising chlamydia antigens
CN103987404A (zh) * 2011-09-30 2014-08-13 英属哥伦比亚大学 衣原体抗原组合物及其用途

Also Published As

Publication number Publication date
WO2014022936A1 (fr) 2014-02-13
CN104812406A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
JP2001518489A (ja) クラミジアタンパク質、その遺伝子配列および使用
JP6515036B2 (ja) Ｃ．ディフィシルＣＤＴｂ及び／又はＣＤＴａタンパク質のエレメントを含む免疫原性組成物
JP2008544745A (ja) Ｃｈｌａｍｙｄｉａｔｒａｃｈｏｍａｔｉｓのための免疫原性組成物
AU2014234765B2 (en) Vaccines against Chlamydia sp.
SI22889A (sl) Himerni flagelini za cepiva
KR100795839B1 (ko) 세균의 편모 구성인자 플라젤린을 유효성분으로 함유하는점막 백신 보조제
CA2881213A1 (fr) Compositions antigeniques de chlamydia et leurs utilisations
DK2907523T3 (en) COMPOSITIONS COMPREHENSIVE KLAMYDIA ANTIGENES.
US20150010591A1 (en) Chlamydia antigen compositions and uses thereof
WO2010089340A2 (fr) Peptides protecteurs contre e. faecalis, procédés et utilisations liés à ceux-ci
CN106536544B (zh) 艰难梭菌免疫原性组合物
US20160045588A1 (en) Chlamydia antigen compositions and uses thereof
KR20220004015A (ko) 로소니아 인트라셀룰라리스 조성물 및 그의 사용 방법
US9610334B2 (en) Truncated secretory aspartyl proteinase 2
US20230241196A1 (en) Gonorrhea subunit vaccine
AU2016349937B2 (en) Chlamydia antigens and uses thereof
US20060240029A1 (en) Chlamydia pneumoniae antigens
WO2002079247A2 (fr) Matieres vivantes et procedes utilisables dans la prevention et le traitement des infections : ii
WO2022125928A1 (fr) Méthodes et compositions pour la production améliorée d'un antigène destiné à être utilisé dans un vaccin s. aureus
CN114315985A (zh) 减毒猪流行性腹泻病毒

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20170808

FZDE Discontinued

Effective date: 20170808